| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phospholipid binding | RAG2 ARHGAP32 AGAP5 APOE TEC GSDMC TULP1 ITPR1 GOLPH3L AGAP9 AGAP7P AGAP4 AGAP6 PREX1 | 6.36e-05 | 548 | 149 | 14 | GO:0005543 |
| GeneOntologyBiologicalProcess | activation of GTPase activity | 1.26e-05 | 109 | 146 | 7 | GO:0090630 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | PLXNA3 AGAP5 RGS6 FGD4 SCRIB AGAP9 AGAP7P AGAP4 AGAP6 PREX1 EPHA1 | 2.74e-05 | 335 | 146 | 11 | GO:0043087 |
| GeneOntologyCellularComponent | cell-cell contact zone | 5.98e-05 | 94 | 150 | 6 | GO:0044291 | |
| GeneOntologyCellularComponent | extrinsic component of synaptic membrane | 1.12e-04 | 35 | 150 | 4 | GO:0099243 | |
| GeneOntologyCellularComponent | npBAF complex | 1.24e-04 | 14 | 150 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | RSC-type complex | 1.55e-04 | 15 | 150 | 3 | GO:0016586 | |
| GeneOntologyCellularComponent | nBAF complex | 1.89e-04 | 16 | 150 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | nuclear envelope | GABRB1 AKAP6 BICD2 ERN1 INPP4A APOE RYR2 ITPR1 DST KASH5 SYNE2 DPY19L4 NUP133 | 2.05e-04 | 560 | 150 | 13 | GO:0005635 |
| GeneOntologyCellularComponent | meiotic spindle | 3.23e-04 | 19 | 150 | 3 | GO:0072687 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 4.69e-04 | 137 | 150 | 6 | GO:0019897 | |
| MousePheno | fused cornea and lens | 1.47e-06 | 24 | 118 | 5 | MP:0001307 | |
| MousePheno | abnormal skin coloration | 2.33e-05 | 182 | 118 | 9 | MP:0011239 | |
| MousePheno | abnormal lens development | 4.98e-05 | 78 | 118 | 6 | MP:0005545 | |
| MousePheno | increased circulating potassium level | 7.29e-05 | 121 | 118 | 7 | MP:0005627 | |
| Domain | BAGE | 1.93e-08 | 5 | 149 | 4 | IPR012530 | |
| Domain | BAGE | 1.93e-08 | 5 | 149 | 4 | PF08180 | |
| Domain | ArfGap | 3.07e-06 | 29 | 149 | 5 | SM00105 | |
| Domain | ARFGAP | 3.07e-06 | 29 | 149 | 5 | PS50115 | |
| Domain | ArfGap | 3.07e-06 | 29 | 149 | 5 | PF01412 | |
| Domain | ArfGAP | 3.07e-06 | 29 | 149 | 5 | IPR001164 | |
| Domain | PH_dom-like | AGAP5 SPRED2 MYO7B TEC FAM43B FRMD1 MPRIP FGD4 TLN2 AGAP9 AGAP7P AGAP4 AGAP6 PREX1 | 8.25e-06 | 426 | 149 | 14 | IPR011993 |
| Domain | SMARCC_C | 6.32e-05 | 2 | 149 | 2 | IPR032451 | |
| Domain | SMARCC_N | 6.32e-05 | 2 | 149 | 2 | IPR032450 | |
| Domain | SWIRM-assoc | 6.32e-05 | 2 | 149 | 2 | IPR032448 | |
| Domain | SWIRM-assoc_2 | 6.32e-05 | 2 | 149 | 2 | PF16496 | |
| Domain | SWIRM-assoc_1 | 6.32e-05 | 2 | 149 | 2 | PF16495 | |
| Domain | SWIRM-assoc_3 | 6.32e-05 | 2 | 149 | 2 | PF16498 | |
| Domain | - | 6.48e-05 | 218 | 149 | 9 | 1.10.10.10 | |
| Domain | BRCT_dom | 6.86e-05 | 28 | 149 | 4 | IPR001357 | |
| Domain | - | AGAP5 SPRED2 MYO7B TEC FAM43B MPRIP FGD4 TLN2 AGAP9 AGAP4 AGAP6 PREX1 | 7.22e-05 | 391 | 149 | 12 | 2.30.29.30 |
| Domain | WHTH_DNA-bd_dom | 1.43e-04 | 242 | 149 | 9 | IPR011991 | |
| Domain | PH | 4.00e-04 | 278 | 149 | 9 | SM00233 | |
| Domain | PH_DOMAIN | 4.11e-04 | 279 | 149 | 9 | PS50003 | |
| Domain | PH_domain | 4.22e-04 | 280 | 149 | 9 | IPR001849 | |
| Domain | RIH_assoc-dom | 9.29e-04 | 6 | 149 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 9.29e-04 | 6 | 149 | 2 | PF08709 | |
| Domain | SWIRM | 9.29e-04 | 6 | 149 | 2 | PS50934 | |
| Domain | RIH_assoc | 9.29e-04 | 6 | 149 | 2 | PF08454 | |
| Domain | RIH_dom | 9.29e-04 | 6 | 149 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 9.29e-04 | 6 | 149 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 9.29e-04 | 6 | 149 | 2 | IPR015925 | |
| Domain | - | 9.29e-04 | 6 | 149 | 2 | 1.25.10.30 | |
| Domain | SWIRM | 9.29e-04 | 6 | 149 | 2 | PF04433 | |
| Domain | RYDR_ITPR | 9.29e-04 | 6 | 149 | 2 | PF01365 | |
| Domain | SWIRM | 9.29e-04 | 6 | 149 | 2 | IPR007526 | |
| Domain | Ankyrin_rpt-contain_dom | 1.00e-03 | 254 | 149 | 8 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.00e-03 | 254 | 149 | 8 | PS50297 | |
| Domain | SCAN | 1.04e-03 | 56 | 149 | 4 | SM00431 | |
| Domain | Znf_FYVE_PHD | 1.17e-03 | 147 | 149 | 6 | IPR011011 | |
| Domain | SCAN_BOX | 1.18e-03 | 58 | 149 | 4 | PS50804 | |
| Domain | SCAN | 1.18e-03 | 58 | 149 | 4 | PF02023 | |
| Domain | SCAN_dom | 1.18e-03 | 58 | 149 | 4 | IPR003309 | |
| Domain | Retrov_capsid_C | 1.26e-03 | 59 | 149 | 4 | IPR008916 | |
| Domain | RNase_Zc3h12a | 1.29e-03 | 7 | 149 | 2 | PF11977 | |
| Domain | RNase_Zc3h12_NYN | 1.29e-03 | 7 | 149 | 2 | IPR021869 | |
| Domain | ETS_DOMAIN_1 | 1.41e-03 | 28 | 149 | 3 | PS00345 | |
| Domain | ETS_DOMAIN_2 | 1.41e-03 | 28 | 149 | 3 | PS00346 | |
| Domain | Ets | 1.41e-03 | 28 | 149 | 3 | PF00178 | |
| Domain | ETS | 1.41e-03 | 28 | 149 | 3 | SM00413 | |
| Domain | Ets_dom | 1.41e-03 | 28 | 149 | 3 | IPR000418 | |
| Domain | ETS_DOMAIN_3 | 1.41e-03 | 28 | 149 | 3 | PS50061 | |
| Domain | Sec1-like | 1.72e-03 | 8 | 149 | 2 | IPR001619 | |
| Domain | Sec-1-like_dom2 | 1.72e-03 | 8 | 149 | 2 | IPR027482 | |
| Domain | Sec1 | 1.72e-03 | 8 | 149 | 2 | PF00995 | |
| Domain | - | 1.72e-03 | 8 | 149 | 2 | 3.40.50.1910 | |
| Domain | SPEC | 2.08e-03 | 32 | 149 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.08e-03 | 32 | 149 | 3 | IPR018159 | |
| Domain | Myb_DNA-binding | 2.70e-03 | 35 | 149 | 3 | PF00249 | |
| Domain | MIR | 2.73e-03 | 10 | 149 | 2 | PF02815 | |
| Domain | MIR_motif | 2.73e-03 | 10 | 149 | 2 | IPR016093 | |
| Domain | MIR | 2.73e-03 | 10 | 149 | 2 | PS50919 | |
| Domain | MIR | 2.73e-03 | 10 | 149 | 2 | SM00472 | |
| Domain | PNT | 3.32e-03 | 11 | 149 | 2 | PS51433 | |
| Domain | SAM_PNT | 3.32e-03 | 11 | 149 | 2 | PF02198 | |
| Domain | PNMA | 3.32e-03 | 11 | 149 | 2 | IPR026523 | |
| Domain | PNMA | 3.32e-03 | 11 | 149 | 2 | PF14893 | |
| Domain | Pointed_dom | 3.32e-03 | 11 | 149 | 2 | IPR003118 | |
| Domain | SAM_PNT | 3.32e-03 | 11 | 149 | 2 | SM00251 | |
| Domain | MYB_LIKE | 3.42e-03 | 38 | 149 | 3 | PS50090 | |
| Domain | - | 3.80e-03 | 248 | 149 | 7 | 1.25.40.20 | |
| Domain | ANK | 4.06e-03 | 251 | 149 | 7 | SM00248 | |
| Domain | ANK_REPEAT | 4.24e-03 | 253 | 149 | 7 | PS50088 | |
| Domain | Ankyrin_rpt | 5.12e-03 | 262 | 149 | 7 | IPR002110 | |
| Domain | ATPase_dyneun-rel_AAA | 5.40e-03 | 14 | 149 | 2 | IPR011704 | |
| Domain | AAA_5 | 5.40e-03 | 14 | 149 | 2 | PF07728 | |
| Domain | FERM_M | 5.88e-03 | 46 | 149 | 3 | PF00373 | |
| Domain | - | 7.01e-03 | 49 | 149 | 3 | 1.20.80.10 | |
| Domain | FERM_central | 7.01e-03 | 49 | 149 | 3 | IPR019748 | |
| Domain | FERM_domain | 7.01e-03 | 49 | 149 | 3 | IPR000299 | |
| Domain | ZF_PHD_2 | 7.07e-03 | 95 | 149 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 7.33e-03 | 96 | 149 | 4 | PS01359 | |
| Domain | SANT | 7.42e-03 | 50 | 149 | 3 | SM00717 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 7.42e-03 | 50 | 149 | 3 | IPR014352 | |
| Domain | FERM_1 | 7.42e-03 | 50 | 149 | 3 | PS00660 | |
| Domain | FERM_2 | 7.42e-03 | 50 | 149 | 3 | PS00661 | |
| Domain | FERM_3 | 7.42e-03 | 50 | 149 | 3 | PS50057 | |
| Domain | Band_41_domain | 7.42e-03 | 50 | 149 | 3 | IPR019749 | |
| Domain | B41 | 7.42e-03 | 50 | 149 | 3 | SM00295 | |
| Domain | Ank_2 | 7.64e-03 | 215 | 149 | 6 | PF12796 | |
| Pubmed | U2SURP EIF3E USP24 DIDO1 DIS3 NDUFS1 LARP7 RBM25 DST MDN1 AHNAK MDC1 SYNE2 NUP133 SMARCA4 SMARCC1 SMARCC2 HECTD1 HCFC1 AQR | 1.54e-11 | 653 | 155 | 20 | 22586326 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 2.05e-10 | 9 | 155 | 5 | 12640130 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 4.08e-10 | 10 | 155 | 5 | 20664521 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 7.45e-10 | 11 | 155 | 5 | 15381706 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | BICD2 HAUS6 U2SURP EIF3E LARP7 CNOT8 MPRIP ITPR1 CKS2 STOX2 AHNAK ASPM NUP133 SMARCA4 SMARCC1 SMARCC2 TLN2 GPC5 SCRIB ESPL1 MRPL24 HCFC1 AQR | 2.01e-09 | 1155 | 155 | 23 | 20360068 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | BICD2 ERG MINK1 USP24 DIDO1 MAPK8IP3 RBM25 MDN1 RPTOR MDC1 SMARCA4 SMARCC1 SMARCC2 TLN2 RIMS1 SCRIB COASY SNAPC4 ESPL1 | 2.04e-09 | 774 | 155 | 19 | 15302935 |
| Pubmed | 2.06e-09 | 13 | 155 | 5 | 27713690 | ||
| Pubmed | AKAP6 AGAP5 JADE2 DIDO1 SPG11 DIS3 STOX2 DST ACSBG1 RPTOR MDC1 AGAP9 AGAP7P ESPL1 AGAP4 AGAP6 | 2.24e-09 | 529 | 155 | 16 | 14621295 | |
| Pubmed | 3.19e-09 | 14 | 155 | 5 | 22453919 | ||
| Pubmed | 5.65e-09 | 6 | 155 | 4 | 12461691 | ||
| Pubmed | 5.65e-09 | 6 | 155 | 4 | 12676563 | ||
| Pubmed | MYO7B MINK1 MPRIP DST MDN1 AHNAK MDC1 ASPM SMARCA4 SMARCC1 SMARCC2 | 9.34e-09 | 234 | 155 | 11 | 36243803 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | CWF19L2 U2SURP DIDO1 RBM25 AHNAK MDC1 SMARCA4 SMARCC1 SMARCC2 HCFC1 AQR | 4.22e-08 | 271 | 155 | 11 | 32433965 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | ARHGAP32 AGAP5 MINK1 STXBP1 AHNAK TLN2 RIMS1 AGAP9 AGAP7P AGAP4 AGAP6 | 6.09e-08 | 281 | 155 | 11 | 28706196 |
| Pubmed | ARHGAP32 MINK1 DIDO1 JAKMIP3 MAPK8IP3 MPRIP STOX2 DST MDN1 RGS6 RPTOR SYNE2 DZIP3 SMARCA4 SMARCC1 SMARCC2 TLN2 RIMS1 SCRIB | 6.63e-08 | 963 | 155 | 19 | 28671696 | |
| Pubmed | PLXNA3 COL20A1 U2SURP SPG11 NDUFS1 RYR2 LARP7 CREBRF DST MDN1 STXBP1 STXBP2 AHNAK DNAJC11 SYNE2 ASPM SMARCC1 SMARCC2 DLEC1 RIMS1 POLQ DNAH8 PREX1 | 1.18e-07 | 1442 | 155 | 23 | 35575683 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | AGAP5 SPRED2 ERN1 MINK1 ITPR1 CREBRF RBM25 TLN2 AGAP9 AGAP7P HECTD1 AGAP4 AGAP6 REV1 | 1.43e-07 | 536 | 155 | 14 | 15840001 |
| Pubmed | AGAP5 SPRED2 ERN1 MINK1 ITPR1 CREBRF RBM25 TLN2 AGAP9 AGAP7P HECTD1 AGAP4 AGAP6 REV1 | 1.50e-07 | 538 | 155 | 14 | 10512203 | |
| Pubmed | The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization. | 3.46e-07 | 4 | 155 | 3 | 15150092 | |
| Pubmed | Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. | 3.46e-07 | 4 | 155 | 3 | 20517297 | |
| Pubmed | 4.51e-07 | 104 | 155 | 7 | 9205841 | ||
| Pubmed | 4.80e-07 | 35 | 155 | 5 | 22325351 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLXNA3 MRPL21 SPRED2 KHNYN FGFRL1 C6orf132 MAPK8IP3 MPRIP DST MDN1 RPTOR AHNAK TLN2 UNKL SNAPC4 ESPL1 HECTD1 PREX1 HCFC1 | 5.41e-07 | 1105 | 155 | 19 | 35748872 |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 6.45e-07 | 218 | 155 | 9 | 33378226 | |
| Pubmed | 6.62e-07 | 16 | 155 | 4 | 37522516 | ||
| Pubmed | 8.39e-07 | 225 | 155 | 9 | 12168954 | ||
| Pubmed | 8.63e-07 | 5 | 155 | 3 | 12244326 | ||
| Pubmed | p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes. | 8.63e-07 | 5 | 155 | 3 | 9584200 | |
| Pubmed | BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. | 8.63e-07 | 5 | 155 | 3 | 7895173 | |
| Pubmed | 8.63e-07 | 5 | 155 | 3 | 18086889 | ||
| Pubmed | AKAP6 BICD2 SPRED2 ERG JADE2 JAKMIP3 APOE DSCAML1 CNOT8 MAPK8IP3 MPRIP DST STXBP1 SCG2 SMARCA4 ZNF624 TLN2 SCRIB HECTD1 PREX1 | 1.24e-06 | 1285 | 155 | 20 | 35914814 | |
| Pubmed | 1.72e-06 | 6 | 155 | 3 | 16940996 | ||
| Pubmed | 1.72e-06 | 6 | 155 | 3 | 10943845 | ||
| Pubmed | 1.72e-06 | 6 | 155 | 3 | 21699904 | ||
| Pubmed | 1.72e-06 | 6 | 155 | 3 | 21095589 | ||
| Pubmed | 1.72e-06 | 6 | 155 | 3 | 16230384 | ||
| Pubmed | 1.74e-06 | 20 | 155 | 4 | 34220450 | ||
| Pubmed | BRIT1/MCPH1 links chromatin remodelling to DNA damage response. | 3.00e-06 | 7 | 155 | 3 | 19525936 | |
| Pubmed | Target genes of the largest human SWI/SNF complex subunit control cell growth. | 3.00e-06 | 7 | 155 | 3 | 21118156 | |
| Pubmed | 3.00e-06 | 7 | 155 | 3 | 28369036 | ||
| Pubmed | U2SURP LARP7 MPRIP CRACD RBM25 DST MDC1 ASPM SMARCA4 SMARCC1 SMARCC2 AQR | 3.13e-06 | 506 | 155 | 12 | 30890647 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 3.15e-06 | 23 | 155 | 4 | 30962207 | |
| Pubmed | GABRB1 BICD2 ARHGAP32 U2SURP MINK1 USP24 NDUFS1 RYR2 MAPK8IP3 ITPR1 STXBP1 ACSBG1 RPTOR DNAJC11 CLTA SMARCC2 TLN2 RIMS1 | 3.58e-06 | 1139 | 155 | 18 | 36417873 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 4.64e-06 | 208 | 155 | 8 | 33230847 | |
| Pubmed | CHD7 cooperates with PBAF to control multipotent neural crest formation. | 4.78e-06 | 8 | 155 | 3 | 20130577 | |
| Pubmed | 4.78e-06 | 8 | 155 | 3 | 36335117 | ||
| Pubmed | 4.78e-06 | 8 | 155 | 3 | 26986003 | ||
| Pubmed | 4.78e-06 | 8 | 155 | 3 | 28940253 | ||
| Pubmed | 4.78e-06 | 8 | 155 | 3 | 9681824 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | MPRIP ITPR1 MDC1 NUP133 SMARCA4 SMARCC1 SMARCC2 SCRIB ESPL1 HECTD1 AQR | 4.97e-06 | 440 | 155 | 11 | 34244565 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 5.83e-06 | 363 | 155 | 10 | 14691545 | |
| Pubmed | ARHGAP32 NAT9 INPP4A MINK1 DGKB APOE NDUFS1 MAPK8IP3 MPRIP CRACD DST STXBP1 CLCN6 FGD4 RPTOR SMARCA4 SMARCC2 TLN2 RIMS1 SCRIB | 6.26e-06 | 1431 | 155 | 20 | 37142655 | |
| Pubmed | HAUS6 USP24 DIDO1 APOE MPRIP RBM25 AHNAK MDC1 SMARCA4 SMARCC1 SCRIB HCFC1 | 7.14e-06 | 549 | 155 | 12 | 38280479 | |
| Pubmed | Chromatin regulation by BAF170 controls cerebral cortical size and thickness. | 7.15e-06 | 28 | 155 | 4 | 23643363 | |
| Pubmed | 7.15e-06 | 9 | 155 | 3 | 37805104 | ||
| Pubmed | 7.15e-06 | 9 | 155 | 3 | 9845365 | ||
| Pubmed | Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. | 7.15e-06 | 9 | 155 | 3 | 20086098 | |
| Pubmed | 7.15e-06 | 9 | 155 | 3 | 22513373 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | PNMA1 BTBD10 EIF3E DIDO1 KCTD1 LARP7 ARL6IP4 MDN1 ASPM NUP133 SMARCA4 ESPL1 HECTD1 AQR | 8.41e-06 | 759 | 155 | 14 | 35915203 |
| Pubmed | 9.50e-06 | 30 | 155 | 4 | 31043422 | ||
| Pubmed | 1.02e-05 | 10 | 155 | 3 | 34716243 | ||
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 1.02e-05 | 10 | 155 | 3 | 16751102 | |
| Pubmed | Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes. | 1.02e-05 | 10 | 155 | 3 | 11238380 | |
| Pubmed | 1.02e-05 | 10 | 155 | 3 | 14729568 | ||
| Pubmed | MRPL21 MINK1 SLC6A15 SPG11 NDUFS1 LARP7 MPRIP ITPR1 MDN1 PTCD1 DNAJC11 SYNE2 CLTA ASPM NUP133 SCRIB COASY ESPL1 MRPL24 AQR | 1.10e-05 | 1487 | 155 | 20 | 33957083 | |
| Pubmed | 1.40e-05 | 11 | 155 | 3 | 12917342 | ||
| Pubmed | Functional selectivity of recombinant mammalian SWI/SNF subunits. | 1.40e-05 | 11 | 155 | 3 | 11018012 | |
| Pubmed | 1.40e-05 | 11 | 155 | 3 | 18003620 | ||
| Pubmed | GABRB1 DENND5B AGAP5 DGKB RGS6 STXBP1 AGAP9 AGAP7P AGAP4 AGAP6 | 1.51e-05 | 405 | 155 | 10 | 38187761 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 1.73e-05 | 180 | 155 | 7 | 30110629 | |
| Pubmed | BICD2 HAUS6 USP24 DIDO1 RBM25 RPTOR NUP133 TLN2 SCRIB HCFC1 EPHA1 | 1.73e-05 | 503 | 155 | 11 | 16964243 | |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 1.82e-05 | 329 | 155 | 9 | 34316702 | |
| Pubmed | 1.85e-05 | 12 | 155 | 3 | 34336815 | ||
| Pubmed | 1.85e-05 | 12 | 155 | 3 | 11734557 | ||
| Pubmed | 1.85e-05 | 12 | 155 | 3 | 33723076 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.97e-05 | 123 | 155 | 6 | 26912792 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 22245845 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 24072183 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 29599780 | ||
| Pubmed | Crucial role of the hydrophobic pocket region of Munc18 protein in mast cell degranulation. | 1.97e-05 | 2 | 155 | 2 | 23487749 | |
| Pubmed | Synergistic Role of Endothelial ERG and FLI1 in Mediating Pulmonary Vascular Homeostasis. | 1.97e-05 | 2 | 155 | 2 | 28248553 | |
| Pubmed | [ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk]. | 1.97e-05 | 2 | 155 | 2 | 15482730 | |
| Pubmed | The Swi3 protein plays a unique role in regulating respiration in eukaryotes. | 1.97e-05 | 2 | 155 | 2 | 27190130 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 10777584 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 10704859 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 30500808 | ||
| Pubmed | Transdifferentiation of erythroblasts to megakaryocytes using FLI1 and ERG transcription factors. | 1.97e-05 | 2 | 155 | 2 | 26063314 | |
| Pubmed | Targeting IRE1 with small molecules counteracts progression of atherosclerosis. | 1.97e-05 | 2 | 155 | 2 | 28137856 | |
| Pubmed | Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease. | 1.97e-05 | 2 | 155 | 2 | 11992569 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 9294126 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 19057022 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 15972970 | ||
| Pubmed | Allosteric interference in oncogenic FLI1 and ERG transactions by mithramycins. | 1.97e-05 | 2 | 155 | 2 | 33275876 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 26642721 | ||
| Pubmed | ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors. | 1.97e-05 | 2 | 155 | 2 | 26122367 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 25111180 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 15653173 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 31051095 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 11397712 | ||
| Pubmed | Loss of atheroprotective effect of estradiol in immunodeficient mice. | 1.97e-05 | 2 | 155 | 2 | 10614672 | |
| Interaction | SIRT7 interactions | U2SURP EIF3E USP24 DIDO1 DIS3 NDUFS1 LARP7 RBM25 DST MDN1 AHNAK MDC1 SYNE2 NUP133 SMARCA4 SMARCC1 SMARCC2 HECTD1 HCFC1 AQR | 5.50e-07 | 744 | 148 | 20 | int:SIRT7 |
| Interaction | SMARCD3 interactions | 1.41e-05 | 107 | 148 | 7 | int:SMARCD3 | |
| Interaction | CDC5L interactions | AKAP6 CWF19L2 ERG U2SURP USP24 LARP7 DST MDN1 ZSCAN1 AHNAK MDC1 DZIP3 SMARCA4 SMARCC2 TLN2 UNKL SCRIB HECTD1 AQR | 1.67e-05 | 855 | 148 | 19 | int:CDC5L |
| Interaction | HERC2 interactions | BICD2 ERG INPP4A U2SURP EIF3E RBM25 DST MDC1 SYNE2 CLTA ASPM SAMD3 HECTD1 AQR | 2.11e-05 | 503 | 148 | 14 | int:HERC2 |
| GeneFamily | ArfGAPs | 1.19e-06 | 33 | 104 | 5 | 395 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 2.32e-06 | 17 | 104 | 4 | 1291 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.93e-06 | 206 | 104 | 9 | 682 | |
| GeneFamily | Ankyrin repeat domain containing | 7.83e-05 | 242 | 104 | 8 | 403 | |
| GeneFamily | ETS transcription factor family | 5.46e-04 | 28 | 104 | 3 | 534 | |
| GeneFamily | Paraneoplastic Ma antigens | 1.74e-03 | 11 | 104 | 2 | 671 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.98e-03 | 50 | 104 | 3 | 1293 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.52e-03 | 53 | 104 | 3 | 532 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 1.95e-07 | 44 | 151 | 6 | MM485 | |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 2.23e-06 | 37 | 151 | 5 | MM1121 | |
| Coexpression | GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN | 2.44e-06 | 199 | 151 | 9 | M7498 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | GABRB1 IRX5 ERN1 RNF213 DIDO1 SYBU RYR2 LARP7 CREBRF RBM25 SYNE2 ASPM DZIP3 SMARCA4 SMARCC1 ANKRD12 GREB1 DNAH8 | 1.11e-05 | 795 | 148 | 18 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | DENND5B FLI1 CWF19L2 HAUS6 IRX5 ERG ETV1 SP110 CRACD CKS2 RBM25 MDN1 SYNE2 MYLK4 ASPM DZIP3 SMARCC1 SMARCC2 ANKRD12 GPC5 GREB1 ZNF454 PREX1 | 1.88e-05 | 1252 | 148 | 23 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.77e-05 | 179 | 148 | 8 | gudmap_developingGonad_e14.5_ ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.86e-05 | 233 | 148 | 9 | gudmap_developingGonad_e12.5_ovary_k5_1000 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.31e-07 | 182 | 153 | 8 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.31e-07 | 182 | 153 | 8 | f7f9be9c7ef8da9864d6aefe20043b26e1bb8697 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-pDC_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-06 | 157 | 153 | 7 | 62f029831c420d3e9580822177545eb7fdf4d0a3 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.71e-06 | 177 | 153 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.37e-06 | 183 | 153 | 7 | f517215ff45dec914af52dfdbc4579c19654c3aa | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-06 | 185 | 153 | 7 | cdd75abdaa1ecedfd2e636203b83a6ac1782f0c3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-06 | 187 | 153 | 7 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-06 | 187 | 153 | 7 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-06 | 187 | 153 | 7 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-06 | 187 | 153 | 7 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-06 | 189 | 153 | 7 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.95e-06 | 194 | 153 | 7 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.85e-06 | 199 | 153 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.85e-06 | 199 | 153 | 7 | 8d13a9ea87f685b5a34b84c4571db6be753cf2d9 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.05e-06 | 200 | 153 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.05e-06 | 200 | 153 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.05e-06 | 200 | 153 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.05e-06 | 200 | 153 | 7 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Healthy_donor-B_cell|World / disease group, cell group and cell class (v2) | 1.34e-05 | 150 | 153 | 6 | a2dfed562de7f58f902b547acec5a13853c80c4c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5_FEZF2_DYRK2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.93e-05 | 160 | 153 | 6 | e2504c6deba4949a3a716a9ca68755f787bc0ae0 | |
| ToppCell | COVID-CD8-CD8_2|COVID / Condition, Cell_class and T cell subcluster | 2.00e-05 | 161 | 153 | 6 | 307dcc17475413cd9eb70c27bc447f938ee5723d | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.38e-05 | 166 | 153 | 6 | c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 167 | 153 | 6 | aef22535a76e93472bcedacbb2c6991f3c9c8cd5 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-dnT|Int-URO / Disease, Lineage and Cell Type | 2.90e-05 | 172 | 153 | 6 | e70299573da1679d6d286c3a43699cbff76e207d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.09e-05 | 174 | 153 | 6 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.09e-05 | 174 | 153 | 6 | 412ccc099028a372b9d953363984c2da54b2187f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-05 | 177 | 153 | 6 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 178 | 153 | 6 | f2002a5c4758d0af6c1880ca12f0af0d5e8888e4 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 3.63e-05 | 179 | 153 | 6 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 180 | 153 | 6 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.86e-05 | 181 | 153 | 6 | 098dbb3e0ff531c9720a233123250c1e39a97d4c | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.86e-05 | 181 | 153 | 6 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-05 | 182 | 153 | 6 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.36e-05 | 185 | 153 | 6 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | PCW_05-06-Neuronal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.63e-05 | 187 | 153 | 6 | 03a2ed85b171c887d4f3b0f4fe2e1cb4a853e658 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-05 | 187 | 153 | 6 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.77e-05 | 188 | 153 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.77e-05 | 188 | 153 | 6 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.05e-05 | 190 | 153 | 6 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-05 | 192 | 153 | 6 | bacbaef1f230051335f4433e55db07a161b96b4c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-05 | 193 | 153 | 6 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.51e-05 | 193 | 153 | 6 | d5930f7bd9b299f792212d40a3272a37adf64a82 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.51e-05 | 193 | 153 | 6 | cdc44bf6f5436eb8a2d4720fe011dcb85ccecf87 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.67e-05 | 194 | 153 | 6 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-05 | 194 | 153 | 6 | a429d22c8c9d0fd3bfa9f877a6364cecad68db30 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.84e-05 | 195 | 153 | 6 | dc84a910b6f6eb9994cd683aa4fd813a82198e5f | |
| ToppCell | Macrophages-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 5.84e-05 | 195 | 153 | 6 | e48bf57e6da23fbb4637a02387155f825455c49f | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.01e-05 | 196 | 153 | 6 | b71d711be5609115b00a57700885aca608920896 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.18e-05 | 197 | 153 | 6 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.18e-05 | 197 | 153 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.35e-05 | 198 | 153 | 6 | 50dfe6efca76ea9683a19b6bff59cb5030d346f1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.35e-05 | 198 | 153 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.35e-05 | 198 | 153 | 6 | 8aa4149d2c1cec73cfd654db093252ec8ec5ef68 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.35e-05 | 198 | 153 | 6 | c8272ac4d90f2367f538f66db40de911ad73ea7f | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.35e-05 | 198 | 153 | 6 | 88b4662be9cc933a402c52673fa5e00fa979c0db | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.35e-05 | 198 | 153 | 6 | 52ddc1f1ed4ac4c3bac794c90b8feb03e3c221c4 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.53e-05 | 199 | 153 | 6 | a76aa30fb264bdcbc0cb09113f814fc5a89e7319 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 6.53e-05 | 199 | 153 | 6 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 6.53e-05 | 199 | 153 | 6 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.53e-05 | 199 | 153 | 6 | a816b0eed80530113b7e720bbd2311a544ed8ed1 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.71e-05 | 200 | 153 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.71e-05 | 200 | 153 | 6 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.71e-05 | 200 | 153 | 6 | 363a8cebf2ace820661bcb87c7941f6671f8e5f3 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-dn_T|Int-URO / Disease, condition lineage and cell class | 6.71e-05 | 200 | 153 | 6 | 020439d9e70fff7246650ab0e9105236688c3ec3 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.71e-05 | 200 | 153 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.71e-05 | 200 | 153 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 6.71e-05 | 200 | 153 | 6 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 6.71e-05 | 200 | 153 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 6.71e-05 | 200 | 153 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.71e-05 | 200 | 153 | 6 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 6.71e-05 | 200 | 153 | 6 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 6.71e-05 | 200 | 153 | 6 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | PBMC-Mild-cDC_2|Mild / Compartment, Disease Groups and Clusters | 1.03e-04 | 135 | 153 | 5 | cb9d834f8301cf53f20e09c3f4cb6a148690196a | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-04 | 142 | 153 | 5 | efe2418436ad1320b8e8fce38619ac65516ef077 | |
| ToppCell | Healthy_donor-B_cell|Healthy_donor / disease group, cell group and cell class (v2) | 1.80e-04 | 152 | 153 | 5 | 5768edfde8010324d8594815e73bbfba2c3045f3 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-04 | 154 | 153 | 5 | d55fb73461885e1e02061a344ff89624ef4de487 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 154 | 153 | 5 | bd283c2367afb99294e7576a0c0167eb7c69ad6b | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-04 | 154 | 153 | 5 | 43735f7c58cac51855ded486ee8d8729a1b9909e | |
| ToppCell | Epithelial-Epithelial-B_(AT1-AT2-progenitors)|Epithelial / shred on cell class and cell subclass (v4) | 1.92e-04 | 154 | 153 | 5 | 770712806e26f73456fb77a81aa4ef8ec78a21ea | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-04 | 157 | 153 | 5 | bd45590da540a557dc8096980a45220fccb99505 | |
| ToppCell | frontal_cortex-Non-neuronal-astrocyte-Astro|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.10e-04 | 157 | 153 | 5 | 0551442ae14685d8fe5729e3960c6324b1e05e4d | |
| ToppCell | frontal_cortex-Non-neuronal-astrocyte|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.10e-04 | 157 | 153 | 5 | 803af734d7f775d294391e2b84e472a732e18cef | |
| ToppCell | frontal_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.10e-04 | 157 | 153 | 5 | 9aa5304a9704da6dd4eda7d6940494b00e38b2e8 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-04 | 157 | 153 | 5 | 00c9a58b033b8b95b0d838f233dd077b62d8b02a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.22e-04 | 159 | 153 | 5 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.22e-04 | 159 | 153 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | COVID-CD4-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 2.22e-04 | 159 | 153 | 5 | 037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 160 | 153 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-gdT|ICU-SEP / Disease, Lineage and Cell Type | 2.29e-04 | 160 | 153 | 5 | 0a14b1fed54a09c0caf263662b5bd426466c7189 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 160 | 153 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.35e-04 | 161 | 153 | 5 | e3327c296d48e821004e61a573abb75624a6f040 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 162 | 153 | 5 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 163 | 153 | 5 | 2e1c1193c04620cc187b1567dfba025beef1e4e1 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 164 | 153 | 5 | a187bd5beca017ef657ef07c006e7f94ea3b911b | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-04 | 166 | 153 | 5 | 7a45785a40b7425f97be67bab1c5ceb69b2bd85a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-04 | 166 | 153 | 5 | ec719368295133da2f7ff587c5329ed6db1dd56d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.71e-04 | 166 | 153 | 5 | 01544c851588f1cde05d6700c3d1167f70a0fbd5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.71e-04 | 166 | 153 | 5 | c22a97353f7eb084f768c13d7767a80b30f05043 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-04 | 166 | 153 | 5 | bbd382812f8a84a5d99888de2d7cca3a8b5e4695 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.79e-04 | 167 | 153 | 5 | c7d1e84af1f4d7430858287520ac2cfa36203642 | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A | DENND5B ARHGAP32 CNOT8 RBM25 MZF1 DZIP3 UNKL SMPD1 ANKRD12 SNAPC4 | 7.78e-07 | 196 | 151 | 10 | 2051_DN |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; HL60; HG-U133A | 3.98e-06 | 184 | 151 | 9 | 1772_DN | |
| Drug | AC1L1B6T | 5.05e-06 | 38 | 151 | 5 | CID000001308 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | 5.63e-06 | 192 | 151 | 9 | 1971_DN | |
| Drug | Parbendazole [14255-87-9]; Up 200; 16.2uM; PC3; HT_HG-U133A | 6.66e-06 | 196 | 151 | 9 | 4535_UP | |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 7.22e-06 | 198 | 151 | 9 | 7327_UP | |
| Drug | Skimmianine [83-95-4]; Up 200; 15.4uM; PC3; HT_HG-U133A | 7.52e-06 | 199 | 151 | 9 | 5766_UP | |
| Drug | indene | 1.56e-05 | 120 | 151 | 7 | CID000007219 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.92e-05 | 171 | 151 | 8 | 4954_DN | |
| Drug | Rabon | 3.32e-05 | 10 | 151 | 3 | CID000013745 | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 3.37e-05 | 185 | 151 | 8 | 1114_DN | |
| Drug | methylene diphosphonate | 3.88e-05 | 29 | 151 | 4 | CID000016124 | |
| Drug | 5230742; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 4.08e-05 | 190 | 151 | 8 | 970_UP | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A | 4.72e-05 | 194 | 151 | 8 | 1217_DN | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A | 4.72e-05 | 194 | 151 | 8 | 3807_DN | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 4.72e-05 | 194 | 151 | 8 | 7221_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 5.65e-05 | 199 | 151 | 8 | 6942_DN | |
| Drug | Aminophylline [317-34-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 5.65e-05 | 199 | 151 | 8 | 5395_UP | |
| Drug | A-skin | 5.79e-05 | 32 | 151 | 4 | CID000208772 | |
| Drug | Epivincamine [6835-99-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 5.86e-05 | 200 | 151 | 8 | 6838_UP | |
| Disease | cerebral palsy (implicated_via_orthology) | 7.32e-10 | 10 | 148 | 5 | DOID:1969 (implicated_via_orthology) | |
| Disease | attempted suicide | 3.44e-06 | 178 | 148 | 8 | EFO_0004321 | |
| Disease | Ewings sarcoma | 6.80e-06 | 8 | 148 | 3 | C0553580 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 1.02e-05 | 9 | 148 | 3 | DOID:0050340 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 6.57e-05 | 268 | 148 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | Sphingomyelin (d18:1/21:0, d17:1/22:0, d16:1/23:0) measurement | 7.47e-05 | 3 | 148 | 2 | EFO_0022111 | |
| Disease | N-palmitoyl-sphinganine (d18:0/16:0) measurement | 7.47e-05 | 3 | 148 | 2 | EFO_0800428 | |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 9.55e-05 | 18 | 148 | 3 | OBA_2045175 | |
| Disease | Sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) measurement | 1.49e-04 | 4 | 148 | 2 | EFO_0022112 | |
| Disease | Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) measurement | 1.49e-04 | 4 | 148 | 2 | EFO_0022116 | |
| Disease | Extra-osseous Ewing's sarcoma | 1.49e-04 | 4 | 148 | 2 | C0279980 | |
| Disease | tyrosine-protein kinase TEC measurement | 1.49e-04 | 4 | 148 | 2 | EFO_0020830 | |
| Disease | palmitoyl sphingomyelin (d18:1/16:0) measurement | 1.49e-04 | 4 | 148 | 2 | EFO_0800300 | |
| Disease | airway responsiveness measurement | 2.32e-04 | 24 | 148 | 3 | EFO_0006897 | |
| Disease | non-alcoholic fatty liver disease, type 2 diabetes mellitus | 2.38e-04 | 110 | 148 | 5 | EFO_0003095, MONDO_0005148 | |
| Disease | Sphingomyelin (d18:1/20:0, d16:1/22:0) measurement | 2.47e-04 | 5 | 148 | 2 | EFO_0022109 | |
| Disease | brain aneurysm | 2.69e-04 | 113 | 148 | 5 | EFO_0003870 | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 2.95e-04 | 26 | 148 | 3 | OBA_2045191 | |
| Disease | stearoyl sphingomyelin (d18:1/18:0) measurement | 3.70e-04 | 6 | 148 | 2 | EFO_0800611 | |
| Disease | C-reactive protein measurement | AKAP6 CWF19L2 HNF1B ZNF573 SLC6A15 SPG11 APOE MAPK8IP3 ITPR1 RBM25 RGS6 PTCD1 AHNAK SMARCA4 SMARCC2 SNAPC4 | 3.80e-04 | 1206 | 148 | 16 | EFO_0004458 |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.67e-04 | 195 | 148 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | palmitoyl dihydrosphingomyelin (d18:0/16:0) measurement | 5.16e-04 | 7 | 148 | 2 | EFO_0800400 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 6.86e-04 | 8 | 148 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | neonatal systemic lupus erythematosus | 8.79e-04 | 9 | 148 | 2 | EFO_0004537 | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 8.79e-04 | 9 | 148 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | PR interval | 9.18e-04 | 495 | 148 | 9 | EFO_0004462 | |
| Disease | myositis | 9.90e-04 | 39 | 148 | 3 | EFO_0000783 | |
| Disease | ceramide measurement | 1.23e-03 | 235 | 148 | 6 | EFO_0010222 | |
| Disease | fructose measurement, glucose measurement, galactose measurement | 1.60e-03 | 12 | 148 | 2 | EFO_0004468, EFO_0010477, EFO_0010481 | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 1.70e-03 | 170 | 148 | 5 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | pulse pressure measurement | CWF19L2 HAUS6 ERG RNF213 APOE TEC GSDMC RBM25 STXBP2 CLCN6 RPTOR TLN2 DLEC1 COASY HCFC1 TEC | 1.72e-03 | 1392 | 148 | 16 | EFO_0005763 |
| Disease | Coffin-Siris syndrome | 1.88e-03 | 13 | 148 | 2 | C0265338 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 1.88e-03 | 13 | 148 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | complement factor H-related protein 4 measurement | 1.92e-03 | 49 | 148 | 3 | EFO_0600091 | |
| Disease | R-6-hydroxywarfarin to R-warfarin ratio measurement | 2.03e-03 | 106 | 148 | 4 | EFO_0803333 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 2.19e-03 | 14 | 148 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | rheumatoid arthritis | 2.38e-03 | 462 | 148 | 8 | EFO_0000685 | |
| Disease | endometrial carcinoma | 2.56e-03 | 113 | 148 | 4 | EFO_1001512 | |
| Disease | Beta blocking agent use measurement | 2.65e-03 | 114 | 148 | 4 | EFO_0009929 | |
| Disease | coronary artery disease | CWF19L2 SPRED2 ERG ETV1 RNF213 APOE TULP1 MAPK8IP3 CRACD STXBP2 RPTOR SMARCA4 DLEC1 PREX1 | 2.80e-03 | 1194 | 148 | 14 | EFO_0001645 |
| Disease | Leber congenital amaurosis | 2.86e-03 | 16 | 148 | 2 | cv:C0339527 | |
| Disease | level of Sterol ester (27:1/18:1) in blood serum | 2.86e-03 | 16 | 148 | 2 | OBA_2045195 | |
| Disease | age at first birth measurement | 3.18e-03 | 120 | 148 | 4 | EFO_0009101 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 3.23e-03 | 17 | 148 | 2 | OBA_2045173 | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 3.27e-03 | 59 | 148 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 3.28e-03 | 121 | 148 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | uterine fibroid | 3.37e-03 | 199 | 148 | 5 | EFO_0000731 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 3.44e-03 | 200 | 148 | 5 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.60e-03 | 61 | 148 | 3 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | migraine disorder, systolic blood pressure | 3.63e-03 | 18 | 148 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 3.63e-03 | 18 | 148 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | angina pectoris | 3.68e-03 | 125 | 148 | 4 | EFO_0003913 | |
| Disease | mean arterial pressure | 3.80e-03 | 499 | 148 | 8 | EFO_0006340 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 3.90e-03 | 127 | 148 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 3.94e-03 | 63 | 148 | 3 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | cystathionine measurement | 4.04e-03 | 19 | 148 | 2 | EFO_0010474 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 4.04e-03 | 19 | 148 | 2 | EFO_0802076 | |
| Disease | Astigmatism | 4.12e-03 | 129 | 148 | 4 | HP_0000483 | |
| Disease | brain age measurement | 4.47e-03 | 20 | 148 | 2 | EFO_0010602 | |
| Disease | retinal vasculature measurement | 4.69e-03 | 517 | 148 | 8 | EFO_0010554 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 4.93e-03 | 21 | 148 | 2 | EFO_0022246 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LELDDWPVELRKVMS | 496 | Q96P64 | |
| TRELDPAWLMVDTVI | 616 | P21709 | |
| VQRPFIRMSWEKEEG | 396 | Q9BSF8 | |
| LDDWPVELRKVMSSI | 566 | Q5VTM2 | |
| QARLKSWFEPLVEDM | 276 | P02649 | |
| QARLMKEESPVVSWR | 16 | Q13072 | |
| ARLVMEAQPEWLRAE | 11 | Q8TD16 | |
| EVEAMLLPETLKRWR | 286 | P01011 | |
| EDDMVEVWRRSVLSP | 141 | P17405 | |
| QERMLRPSEWNRDTL | 446 | Q8IUR6 | |
| MTDPDEVARRWGERK | 341 | P11308 | |
| ELDNPRSTWDVEAKM | 476 | Q9BYG8 | |
| MEKEETTRELLLPNW | 1 | Q09666 | |
| IRQDIEDSVSRMKPW | 481 | O60306 | |
| NKSWEMPVDRLETLS | 1416 | Q6UB98 | |
| DWIMENPVLHREKER | 121 | Q9P1Z9 | |
| KPDWVLRRDNMEEIT | 3446 | Q8IZT6 | |
| LELDDWPVELRKVMS | 496 | Q5VW22 | |
| KRSRIPMETLETWEE | 181 | Q96D70 | |
| PMETLETWEERLLRF | 186 | Q96D70 | |
| KIEIREMETPDWTPD | 296 | P55895 | |
| PLDWSIVDSILMERR | 756 | P49756 | |
| LWDIEMSKEPSQQRV | 316 | P49758 | |
| KMTWTPRNRSEDEEE | 176 | P78411 | |
| WQMEEKSDQRPPVTR | 171 | Q96PE3 | |
| GRKEPSMWLTRREEE | 436 | Q8N6L0 | |
| PTRLRVEMEDWEGNL | 216 | O43827 | |
| WETILMDTLEDNIPR | 306 | P51610 | |
| LRDAPMDSIEWAEVV | 711 | Q8WUM0 | |
| LEMEGWEVVERRRTP | 86 | Q9NVH1 | |
| MRRIIAEDPEWSLAI | 61 | Q5JU00 | |
| QELERQLEMWQPRES | 5286 | Q9NU22 | |
| STLWQEEMRTKDQPD | 201 | Q6WCQ1 | |
| IWNRDAEEDMPQRVV | 426 | Q14676 | |
| KELPEMDATSSRVWI | 761 | Q9UPT6 | |
| LRMWQKIEDVEWRPQ | 1001 | Q4ZG55 | |
| VAEMIKERNLDWFPR | 2671 | Q14643 | |
| EVKRTLKITDWMPDD | 511 | P78333 | |
| PWRAREGLEKMVAED | 5791 | Q03001 | |
| MLPWRRNKFVLVEDE | 1 | Q6ZT52 | |
| GVLDEETKEWMKRPR | 96 | P51511 | |
| WLELINSELKEMERP | 146 | Q9NQC1 | |
| PRDFALDVEMKLWRQ | 1151 | P98095 | |
| SQRPKAEDMDLEWRQ | 1521 | P51805 | |
| DITWMKDDQALTRPE | 181 | Q8N441 | |
| LLEMERWKQDRETGR | 121 | Q719H9 | |
| RLRGEDTWMLPDVNE | 51 | Q2TBE0 | |
| MEFKLIEPEEVARRW | 361 | P50549 | |
| WEMELRARKIPFTEN | 3411 | Q96JB1 | |
| ELEKRMQEWETTPRI | 271 | Q96M96 | |
| EVWSNADLTERMPVK | 56 | Q86YV6 | |
| EQWKRQVMSELRERD | 776 | Q5VZ66 | |
| EEVIPLRVLSKSEWM | 371 | Q4G0J3 | |
| MIDTTKNDDTPWIAR | 581 | Q6ZN66 | |
| PDLTDVNSIDKWSRM | 441 | P18505 | |
| EVRLSKEMERPWVRQ | 1941 | A7KAX9 | |
| RSDPSIMNWERITDR | 1026 | Q86Y13 | |
| EMLDTVRQQWPELEK | 266 | Q9NZB8 | |
| RMLEITVWDQPRVQE | 826 | Q86UR5 | |
| DMELWPRELTELEKE | 546 | B2RXH4 | |
| QARLMKEESPVVSWR | 16 | Q86Y29 | |
| WRDPSQMEKLRNELA | 461 | Q5T0Z8 | |
| WLRESREMSVDVPLE | 406 | Q8N878 | |
| QLRWETMDVRKLDFP | 106 | P0DPD8 | |
| PLLEWETEVEMDKLR | 586 | P51797 | |
| ERVKVPRGESLMEWA | 2131 | Q9ULT8 | |
| RTIPEEELTDNWRKM | 1486 | Q14674 | |
| ESRMRKLWERLPQET | 216 | Q8NEX9 | |
| KMDWRENITVPLQTD | 871 | O75460 | |
| EERKRGPMETFEDLW | 141 | I3L3R5 | |
| VLPEDRLQMKWRESE | 36 | Q9P218 | |
| RWEKGDTVIDPDRVM | 821 | Q8TD84 | |
| WKMIEPESVGDDLRQ | 2366 | O75417 | |
| ELRWQEVDERQTMPR | 521 | Q6ZU35 | |
| GRKMEIVDDDVPSLW | 126 | P26998 | |
| MTDPDEVARRWGERK | 311 | Q01543 | |
| SVLERWVNDPQRMDK | 206 | Q9H4A5 | |
| DPDTVELMTWIKRQA | 561 | Q7Z388 | |
| EIMLDRWKFEVIPND | 556 | Q9Y6T7 | |
| ELSTWKERPARSVME | 766 | Q9BTC0 | |
| MSQWEEKDPLLRVFD | 576 | Q6ZUT9 | |
| PRVWEKIMERIQEVA | 376 | Q96GR2 | |
| LELDDWPVELRKVMS | 496 | Q5VUJ5 | |
| PMTKEEWDARQSIIR | 171 | Q66PJ3 | |
| LADKLNMTPEEAERW | 356 | P60228 | |
| MEWKLERTAPRRVRT | 1 | Q86Y33 | |
| TERPELANKVDMIWI | 101 | Q86XF0 | |
| WRKAIEMEENRTKEP | 596 | Q7Z4H7 | |
| ESEKWMAIIRERLLP | 551 | O15037 | |
| WASNLEEEMRKIREI | 16 | Q9UFF9 | |
| PSRQEKEGSRVEMWN | 1381 | P82279 | |
| NLETERMPSHKEERW | 241 | Q02742 | |
| QARLMKEESPVVSWR | 16 | Q86Y30 | |
| QARLMKEESPVVSWR | 16 | Q86Y27 | |
| ATWRMKESPVSLQER | 891 | Q9Y238 | |
| WQVSDVEKRRRLMES | 191 | Q8ND90 | |
| MVRWAQESVIEDPEL | 2066 | Q92736 | |
| KPAWAREVEERTRMN | 516 | Q8N4C8 | |
| QRAEVDRMLSEDPWR | 106 | P35680 | |
| EIMLEPKVWREAATQ | 291 | Q9H2J7 | |
| DMEDPREIQTDSWRK | 6366 | Q8WXH0 | |
| EKWEINPSELTFMRE | 361 | P42680 | |
| RPWETRKTESIDVMD | 241 | P28331 | |
| DWREIDKRMSQTLEI | 301 | Q8N6K7 | |
| WLRPDIRTKEQIVEM | 136 | P57086 | |
| PATVKEERTMLEDIW | 1386 | Q8TCU6 | |
| ERDSLSEEDWMRIIL | 101 | P13521 | |
| RLMEEDELPSWIIKD | 1336 | P51532 | |
| VWRERMVEPENAVTI | 811 | Q14160 | |
| EPFQEAMWLDLVKER | 611 | Q9HB58 | |
| SRWTPIIKDIMEDTI | 476 | P61764 | |
| MDRKPTEIEWRFTEA | 126 | Q96A35 | |
| PWSITEKDMKNREDL | 456 | Q9Y2L1 | |
| SSQDDEEWLRPVMRK | 211 | Q92922 | |
| EEEEWVRPVMKRDKQ | 186 | Q8TAQ2 | |
| QLRWETMDVRKLDFP | 106 | P0DPD7 | |
| IVRIWDTDREMKVQD | 1146 | Q8N122 | |
| ASVKIMWPRTDEERA | 301 | O15042 | |
| PEIETWLRMTSERVR | 71 | Q13023 | |
| LDDWPVELRKVMSSI | 521 | A6NIR3 | |
| DPELRMEETWQSIKI | 71 | Q7Z7G1 | |
| QVPKTHLMSEEEWRR | 31 | P33552 | |
| EPESIRKWREEQMER | 106 | P09496 | |
| TDIMWPIIAKLAREE | 441 | Q13057 | |
| MPIWQVSEVEKRRRL | 186 | Q96PV4 | |
| RSWKIMHISEQEEPI | 411 | Q96JI7 | |
| MPLRDETLREVWASD | 1 | O00294 | |
| MEWRLTKEEPLSQIT | 961 | Q63HN8 | |
| EEWRLMDPTQRNLHK | 66 | Q9P2J8 | |
| EKVEQLMEWSSRRSI | 51 | Q13454 | |
| SIDNEWRKTQCMPRE | 121 | P49767 | |
| LERGKEPWMILREET | 81 | Q86YE8 | |
| AVDITQEDWELMRPV | 176 | Q9HBT7 | |
| LLREWITTISDPMEE | 1171 | Q9UBZ9 | |
| ELKSQLARMREDWIE | 301 | Q9NX95 | |
| REDVGTMQWLLEREK | 796 | Q9P2F5 | |
| WLRPEARSKEQMLEL | 66 | Q8NBB4 | |
| QLSRWTPVIKDVMED | 471 | Q15833 | |
| DLSVTSMLEQKRDPW | 66 | Q76KX8 | |
| DEEIVRINPREKIWM | 211 | Q7Z698 | |
| IEKTESWPRIIMRFR | 161 | Q7Z2W9 | |
| RSVAMEPEEWLSIAR | 441 | Q5HYM0 | |
| AMIEKILSEDPRWQD | 186 | Q9H9P5 | |
| RISPATMLEDEITWL | 1531 | Q9UPU5 | |
| MRVDEKTKEVLQEWP | 341 | Q9Y4G6 | |
| DTFSQLEKREVWMPE | 61 | Q8N9F8 | |
| RARTILEFEKMLPEW | 696 | Q8NET8 | |
| RKEWTEEEDRMLTQL | 346 | Q5SXM2 | |
| SLSMKTPEERLEWSE | 81 | Q9NVR7 | |
| ERRDEQMEPEPKLWR | 116 | O75127 | |
| EELSTLPRVLQEWKM | 166 | Q96MR9 | |
| LAMKTELPEDRIQVW | 181 | P58304 | |
| VPENLTRLMSSEEWK | 1961 | Q6PIF6 | |
| WMKSEELQRLTASEP | 31 | Q9BTE0 | |
| QWLRPEVRSKEQMLE | 71 | P28698 |